- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
- Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
- Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
More ▼
Key statistics
On Thursday, Bio Rad Laboratories Inc (BIO:NYQ) closed at 345.87, 32.22% above the 52 week low of 261.59 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 350.32 |
---|---|
High | 350.32 |
Low | 345.05 |
Bid | 283.17 |
Offer | 500.67 |
Previous close | 349.56 |
Average volume | 179.90k |
---|---|
Shares outstanding | 28.52m |
Free float | 19.98m |
P/E (TTM) | -- |
Market cap | 9.88bn USD |
EPS (TTM) | -21.49 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.
More ▼